Scientists have discovered a jab that could prevent rheumatoid arthritis (RA), a development experts say could offer hope to millions at risk of the disease.
About 18 million people globally are affected by the condition, which can lead to heart, lung or nervous system problems, according to the World Health Organization.
Now researchers have found that an existing drug for RA, which patients can inject into their stomach or thigh, could help slow its progression in those with early symptoms or stop it in its tracks altogether.
Abatacept is prescribed to people who already have RA, but a team led by King’s College London explored whether it could prevent it in those deemed at risk.
“These initial results could be good news for people at risk of arthritis as we show that the drug not only prevents disease onset during the treatment phase but can also ease symptoms such as pain and fatigue.”
The trial also showed other outcomes of using abatacept, such as lower pain scores and higher quality of life measurements among patients.
The original article contains 591 words, the summary contains 175 words. Saved 70%. I’m a bot and I’m open source!
This is the best summary I could come up with:
Scientists have discovered a jab that could prevent rheumatoid arthritis (RA), a development experts say could offer hope to millions at risk of the disease.
About 18 million people globally are affected by the condition, which can lead to heart, lung or nervous system problems, according to the World Health Organization.
Now researchers have found that an existing drug for RA, which patients can inject into their stomach or thigh, could help slow its progression in those with early symptoms or stop it in its tracks altogether.
Abatacept is prescribed to people who already have RA, but a team led by King’s College London explored whether it could prevent it in those deemed at risk.
“These initial results could be good news for people at risk of arthritis as we show that the drug not only prevents disease onset during the treatment phase but can also ease symptoms such as pain and fatigue.”
The trial also showed other outcomes of using abatacept, such as lower pain scores and higher quality of life measurements among patients.
The original article contains 591 words, the summary contains 175 words. Saved 70%. I’m a bot and I’m open source!